349 related articles for article (PubMed ID: 30938764)
1. Metformin Improves Peripheral Insulin Sensitivity in Youth With Type 1 Diabetes.
Cree-Green M; Bergman BC; Cengiz E; Fox LA; Hannon TS; Miller K; Nathan B; Pyle L; Kahn D; Tansey M; Tichy E; Tsalikian E; Libman I; Nadeau KJ
J Clin Endocrinol Metab; 2019 Aug; 104(8):3265-3278. PubMed ID: 30938764
[TBL] [Abstract][Full Text] [Related]
2. Metformin Improves Insulin Sensitivity and Vascular Health in Youth With Type 1 Diabetes Mellitus.
Bjornstad P; Schäfer M; Truong U; Cree-Green M; Pyle L; Baumgartner A; Garcia Reyes Y; Maniatis A; Nayak S; Wadwa RP; Browne LP; Reusch JEB; Nadeau KJ
Circulation; 2018 Dec; 138(25):2895-2907. PubMed ID: 30566007
[TBL] [Abstract][Full Text] [Related]
3. Insulin resistance in type 1 diabetes managed with metformin (INTIMET): Study protocol of a double-blind placebo-controlled, randomised trial.
Snaith JR; Samocha-Bonet D; Evans J; Liu Z; Kowalski G; Bruce C; Holmes-Walker DJ; Greenfield JR
Diabet Med; 2021 Sep; 38(9):e14564. PubMed ID: 33774848
[TBL] [Abstract][Full Text] [Related]
4. Effect of Metformin Added to Insulin on Glycemic Control Among Overweight/Obese Adolescents With Type 1 Diabetes: A Randomized Clinical Trial.
Libman IM; Miller KM; DiMeglio LA; Bethin KE; Katz ML; Shah A; Simmons JH; Haller MJ; Raman S; Tamborlane WV; Coffey JK; Saenz AM; Beck RW; Nadeau KJ;
JAMA; 2015 Dec; 314(21):2241-50. PubMed ID: 26624824
[TBL] [Abstract][Full Text] [Related]
5. Youth With Type 1 Diabetes Have Adipose, Hepatic, and Peripheral Insulin Resistance.
Cree-Green M; Stuppy JJ; Thurston J; Bergman BC; Coe GV; Baumgartner AD; Bacon S; Scherzinger A; Pyle L; Nadeau KJ
J Clin Endocrinol Metab; 2018 Oct; 103(10):3647-3657. PubMed ID: 30020457
[TBL] [Abstract][Full Text] [Related]
6. Youth with type 2 diabetes have hepatic, peripheral, and adipose insulin resistance.
Cree-Green M; Wiromrat P; Stuppy JJ; Thurston J; Bergman BC; Baumgartner AD; Bacon S; Scherzinger A; Pyle L; Nadeau KJ
Am J Physiol Endocrinol Metab; 2019 Feb; 316(2):E186-E195. PubMed ID: 30562061
[TBL] [Abstract][Full Text] [Related]
7. A Randomized, Double-Blind, Placebo-Controlled Trial of Adjunctive Metformin Therapy in Overweight/Obese Youth with Type 1 Diabetes.
Nwosu BU; Maranda L; Cullen K; Greenman L; Fleshman J; McShea N; Barton BA; Lee MM
PLoS One; 2015; 10(9):e0137525. PubMed ID: 26367281
[TBL] [Abstract][Full Text] [Related]
8. Metformin as additional therapy in adolescents with poorly controlled type 1 diabetes: randomised placebo-controlled trial with aspects on insulin sensitivity.
Särnblad S; Kroon M; Aman J
Eur J Endocrinol; 2003 Oct; 149(4):323-9. PubMed ID: 14514347
[TBL] [Abstract][Full Text] [Related]
9. The SGLT2 Inhibitor Dapagliflozin Reduces Liver Fat but Does Not Affect Tissue Insulin Sensitivity: A Randomized, Double-Blind, Placebo-Controlled Study With 8-Week Treatment in Type 2 Diabetes Patients.
Latva-Rasku A; Honka MJ; Kullberg J; Mononen N; Lehtimäki T; Saltevo J; Kirjavainen AK; Saunavaara V; Iozzo P; Johansson L; Oscarsson J; Hannukainen JC; Nuutila P
Diabetes Care; 2019 May; 42(5):931-937. PubMed ID: 30885955
[TBL] [Abstract][Full Text] [Related]
10. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
Freemark M; Bursey D
Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
[TBL] [Abstract][Full Text] [Related]
11. Metformin for early comorbid glucose dysregulation and schizophrenia spectrum disorders: a pilot double-blind randomized clinical trial.
Agarwal SM; Panda R; Costa-Dookhan KA; MacKenzie NE; Treen QC; Caravaggio F; Hashim E; Leung G; Kirpalani A; Matheson K; Chintoh AF; Kramer CK; Voineskos AN; Graff-Guerrero A; Remington GJ; Hahn MK
Transl Psychiatry; 2021 Apr; 11(1):219. PubMed ID: 33854039
[TBL] [Abstract][Full Text] [Related]
12. Achieving ADA/ISPAD clinical guideline goals is associated with higher insulin sensitivity and cardiopulmonary fitness in adolescents with type 1 diabetes: Results from RESistance to InSulin in Type 1 ANd Type 2 diabetes (RESISTANT) and Effects of MEtformin on CardiovasculaR Function in AdoLescents with Type 1 Diabetes (EMERALD) Studies.
Bjornstad P; Cree-Green M; Baumgartner A; Coe G; Reyes YG; Schäfer M; Pyle L; Regensteiner JG; Reusch JE; Nadeau KJ
Pediatr Diabetes; 2018 May; 19(3):436-442. PubMed ID: 29082640
[TBL] [Abstract][Full Text] [Related]
13. Effects of Conjugated Linoleic Acid and Metformin on Insulin Sensitivity in Obese Children: Randomized Clinical Trial.
Garibay-Nieto N; Queipo-García G; Alvarez F; Bustos M; Villanueva E; Ramírez F; León M; Laresgoiti-Servitje E; Duggirala R; Macías T; Cuevas S; Jalife A; Fonseca-Sánchez M; Serratos F; López-Alvarenga JC
J Clin Endocrinol Metab; 2017 Jan; 102(1):132-140. PubMed ID: 27778642
[TBL] [Abstract][Full Text] [Related]
14. Metformin for overweight women at midlife: a double-blind, randomized, controlled trial.
Worsley R; Jane F; Robinson PJ; Bell RJ; Davis SR
Climacteric; 2015 Apr; 18(2):270-7. PubMed ID: 25333776
[TBL] [Abstract][Full Text] [Related]
15. Vitamin B12 and Folate Concentrations in Recent-onset Type 2 Diabetes and the Effect of Metformin Treatment.
Kanti G; Anadol-Schmitz E; Bobrov P; Strassburger K; Kahl S; Zaharia OP; Sarabhai T; Karusheva Y; Burkart V; Markgraf DF; Trenkamp S; Ziegler D; Szendroedi J; Roden M;
J Clin Endocrinol Metab; 2020 Jun; 105(6):. PubMed ID: 32219330
[TBL] [Abstract][Full Text] [Related]
16. Effects of low dose metformin in adolescents with type I diabetes mellitus: a randomized, double-blinded placebo-controlled study.
Nadeau KJ; Chow K; Alam S; Lindquist K; Campbell S; McFann K; Klingensmith G; Walravens P
Pediatr Diabetes; 2015 May; 16(3):196-203. PubMed ID: 24698216
[TBL] [Abstract][Full Text] [Related]
17. Variation in inflammatory markers and glycemic parameters after 12 months of exenatide plus metformin treatment compared with metformin alone: a randomized placebo-controlled trial.
Derosa G; Franzetti IG; Querci F; Carbone A; Ciccarelli L; Piccinni MN; Fogari E; Maffioli P
Pharmacotherapy; 2013 Aug; 33(8):817-26. PubMed ID: 23744726
[TBL] [Abstract][Full Text] [Related]
18. Effect of Metformin on Vascular Function in Children With Type 1 Diabetes: A 12-Month Randomized Controlled Trial.
Anderson JJA; Couper JJ; Giles LC; Leggett CE; Gent R; Coppin B; Peña AS
J Clin Endocrinol Metab; 2017 Dec; 102(12):4448-4456. PubMed ID: 29040598
[TBL] [Abstract][Full Text] [Related]
19. Long-term treatment with metformin in obese, insulin-resistant adolescents: results of a randomized double-blinded placebo-controlled trial.
van der Aa MP; Elst MA; van de Garde EM; van Mil EG; Knibbe CA; van der Vorst MM
Nutr Diabetes; 2016 Aug; 6(8):e228. PubMed ID: 27571249
[TBL] [Abstract][Full Text] [Related]
20. Rosiglitazone treatment increases subcutaneous adipose tissue glucose uptake in parallel with perfusion in patients with type 2 diabetes: a double-blind, randomized study with metformin.
Viljanen AP; Virtanen KA; Järvisalo MJ; Hällsten K; Parkkola R; Rönnemaa T; Lönnqvist F; Iozzo P; Ferrannini E; Nuutila P
J Clin Endocrinol Metab; 2005 Dec; 90(12):6523-8. PubMed ID: 16189256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
